{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:55:46Z","timestamp":1760147746592,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: UVA1 phototherapy is a treatment used for multiple dermatological conditions. The optimal therapeutic regimens and dosing of UVA1 are a matter of debate. The dosages used vary widely between published studies and there are no evidence-based protocols that provide data on dosage, duration, or the role of maintenance therapy. The purpose of this study is to evaluate the experience in our medical center regarding treatment with UVA1, as well as the degree of patient satisfaction with the treatment according to their pathology. Methods: We present a retrospective evaluation of outcomes, treatment tolerability, and satisfaction in adult patients using a low dose of UVA1 phototherapy, administered in our dermatologic service between 2019 and 2022. Results: A total of 78 patients were treated with UVA1, of whom 46 patients (59%) were over 18 years old, completed treatment, and gave their consent. The overall objective clinical response rate was 91.30% (42\/46), achieving a complete response in 17 (36.96%) patients, partial response in 25 (54.34%), and no response in 4 (8.70%). The complete response rates recorded were high in morphea, scleredema, or chronic hand eczema. In terms of the level of satisfaction objectively measured by TSQM-9 version 1.4, highlighting high scores obtained in mastocytosis, systemic sclerosis, morphea, scleredema, chronic hand eczema, or prurigo nodularis (over 65 points). Conclusions: We present a review of treatment with UVA1 phototherapy at low doses with good response in a wide variety of dermatological pathologies.<\/jats:p>","DOI":"10.3390\/life13030669","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T03:03:48Z","timestamp":1677639828000},"page":"669","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Satisfaction of Low Doses UVA1 Phototherapy: A Spanish Experience from a Single Centre"],"prefix":"10.3390","volume":"13","author":[{"given":"Juan Pablo","family":"Velasco-Amador","sequence":"first","affiliation":[{"name":"Department of Dermatology, Hospital Universitario San Cecilio, 18016 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Linares-Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Universitario San Cecilio, 18016 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4400-7859","authenticated-orcid":false,"given":"Francisco Javier","family":"De la Torre-Gomar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Universitario San Cecilio, 18016 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.det.2019.08.011","article-title":"Utilizing UVA-1 Phototherapy","volume":"38","author":"Prasad","year":"2020","journal-title":"Dermatol. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/ajd.13321","article-title":"A retrospective review of UVA1 treatment: An Australian experience from a single centre","volume":"61","author":"Pitney","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0781.2006.00245.x","article-title":"UVA1 phototherapy for cutaneous diseases: An experience of 92 cases in the United States","volume":"22","author":"Tuchinda","year":"2006","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clindermatol.2013.01.011","article-title":"Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: Facts and controversies","volume":"31","author":"Gambichler","year":"2013","journal-title":"Clin. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.0022-202X.2003.22106.x","article-title":"Different Susceptibility of Malignant versus Nonmalignant Human T Cells toward Ultraviolet A-1 Radiation-Induced Apoptosis","volume":"122","author":"Yamauchi","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2133.2007.07802.x","article-title":"Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation","volume":"156","author":"Gambichler","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2008.07.042","article-title":"Ultraviolet A phototherapy for sclerotic skin diseases: A systematic review","volume":"59","author":"Kroft","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/phpp.12786","article-title":"Clinical and laboratory characterization of patients with localized scleroderma and response to UVA -1 phototherapy: In vivo and in vitro skin models","volume":"38","author":"Tognetti","year":"2022","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fmed.2018.00237","article-title":"Ultraviolet A1 Phototherapy for Fibrosing Conditions","volume":"5","author":"Gambichler","year":"2018","journal-title":"Front. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/phpp.12185","article-title":"Ultraviolet A1 phototherapy beyond morphea: Experience in 83 patients","volume":"31","author":"Connolly","year":"2015","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(97)80277-0","article-title":"High-dose UVA1 radiation therapy for localized scleroderma","volume":"36","author":"Stege","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/1346-8138.15368","article-title":"Ultraviolet A1 phototherapy for the treatment of localized scleroderma","volume":"47","author":"Furuhashi","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12703\/r\/10-43","article-title":"Emerging treatments for scleroderma\/systemic sclerosis","volume":"10","author":"Zhu","year":"2021","journal-title":"Fac. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0781.2004.00081.x","article-title":"Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. A clinico-pathologic study","volume":"20","author":"Mostafa","year":"2004","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-0781.2007.00308.x","article-title":"Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: Controlled study with half-side comparison analysis","volume":"23","author":"Durand","year":"2007","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaad.2003.08.026","article-title":"Low-dose UVA1 phototherapy in systemic sclerosis: Effects on acrosclerosis","volume":"50","author":"Kreuter","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0781.2009.00422.x","article-title":"Low-dose UVA1 pho- totherapy for proximal and acral scleroderma in systemic sclerosis","volume":"25","author":"Rose","year":"2009","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mjd.2002.118552","article-title":"Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: Results of a preliminary study","volume":"46","author":"Kreuter","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ad.2019.10.011","article-title":"Escleredema de Buschke refractario a terapia convencional. Respuesta a UVA1","volume":"112","year":"2021","journal-title":"Actas Dermosifiliogr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0781.2004.00106.x","article-title":"UVA-1 as a treatment for scleredema","volume":"20","author":"Janiga","year":"2004","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00105-011-2150-9","article-title":"Scleredema diabeticorum: Successful treatment with UVA-1 phototherapy","volume":"62","author":"Kochs","year":"2011","journal-title":"Hautarzt"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1346-8138.2010.01014.x","article-title":"Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy","volume":"37","author":"Thumpimukvatana","year":"2010","journal-title":"J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archderm.144.7.947","article-title":"Scleredema Diabeticorum Case Series: Successful Treatment With UV-A1","volume":"144","author":"Kroft","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/000155599750010076","article-title":"UVA1 for treatment of keloids","volume":"79","author":"Grandal","year":"1999","journal-title":"Acta Derm. Venereol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/dermatopathology7030009","article-title":"Histological Changes Related to Symptomatic Improvement of Spontaneous Keloids Treated with a Low-Dosage Regimen of UVA-1 Phototherapy","volume":"7","year":"2020","journal-title":"Dermatopathology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: Section Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/ijd.14011","article-title":"UVA-1 phototherapy for the management of atopic dermatitis: A large retrospective study conducted in a low-middle income country","volume":"57","author":"Arenas","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Musters, A.H., Mashayekhi, S., Flohr, C., Drucker, A.M., Gerbens, L., Ferguson, J., Ibbotson, S., and Dawe, R.S. (2021). Phototherapy for atopic eczema. Cochrane Libr., 10.","DOI":"10.1002\/14651858.CD013870"},{"key":"ref_29","first-page":"387","article-title":"Phototherapy in Atopic Dermatitis: A Systematic Review of the Literature","volume":"106","author":"Aranegui","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0781.2007.00291.x","article-title":"Phototherapy in the management of atopic dermatitis: A systematic review","volume":"23","author":"Meduri","year":"2007","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.5114\/ada.2019.88465","article-title":"The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis","volume":"37","author":"Malinowska","year":"2020","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2015.09.033","article-title":"Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium","volume":"74","author":"Olsen","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000458149","article-title":"Ultraviolet A1 Phototherapy in the Treatment of Early Mycosis Fungoides","volume":"233","author":"Erduran","year":"2017","journal-title":"Dermatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5021\/ad.2013.25.1.104","article-title":"Ultraviolet A1 Phototherapy of Mycosis Fungoides","volume":"25","author":"Jang","year":"2013","journal-title":"Ann. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40257-021-00636-1","article-title":"Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options","volume":"23","author":"Joshi","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000507247","article-title":"A Monocentric, Retrospective Analysis of 61 Patients with Generalized Granuloma Annulare","volume":"236","author":"Nordmann","year":"2020","journal-title":"Dermatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bjd.17606","article-title":"Patch granuloma annulare: Clinicopathological characteristics and response to phototherapy","volume":"181","author":"Aichelburg","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/phpp.12756","article-title":"Light- and laser-based treatments for granuloma annulare: A systematic review","volume":"38","author":"Mukovozov","year":"2022","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/S0190-9622(03)01483-X","article-title":"Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: A pilot study","volume":"49","author":"Gobello","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(96)91600-1","article-title":"High-dose UVA1 for urticaria pigmentosa","volume":"347","author":"Stege","year":"1996","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000018440","article-title":"Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy","volume":"201","author":"Kreuter","year":"2000","journal-title":"Dermatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ad.2020.11.007","article-title":"Fototerapia en el prurigo nodular. Experiencia propia y revisi\u00f3n de la literatura","volume":"112","author":"Arrieta","year":"2021","journal-title":"Actas Dermosifiliogr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0781.2008.00328.x","article-title":"Efficacy of UVA1 phototherapy in 230 patients with various skin diseases","volume":"24","author":"Rombold","year":"2008","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2230.2009.03705.x","article-title":"Phototherapy of generalized prurigo nodularis","volume":"35","author":"Bruni","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/000155598442089","article-title":"UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema","volume":"78","author":"Schmidtt","year":"1998","journal-title":"Acta Derm Venereol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-2230.2003.01378.x","article-title":"A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema: UVA-1 for dyshidrotic eczema","volume":"28","author":"Polderman","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0190-9622(03)00782-5","article-title":"Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema","volume":"50","author":"Petering","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00105-008-1561-8","article-title":"Neue und seltener angewandte Therapieoptionen bei therapie refrakta\u00e4rem Handekzem","volume":"59","author":"Raap","year":"2008","journal-title":"Hautarzt"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/3\/669\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:44:40Z","timestamp":1760121880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/3\/669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["life13030669"],"URL":"https:\/\/doi.org\/10.3390\/life13030669","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}